Fischer Medical Ventures clarifies dividend post-stock split

Fischer Medical Ventures Limited, formerly Fischer Chemic Limited, has issued a clarification regarding its dividend distribution following a recent stock split. The company's board of directors initially recommended a dividend of 0.5% on the face value of ₹10 per equity share (₹0.05 per share) on May 28, 2025, with a record date fixed for September 22, 2025.

Subsequently, on July 28, 2025, the board approved a stock split, changing the face value from ₹10 to ₹1 per equity share. This split was approved by members via postal ballot, which concluded on August 30, 2025. The record date for the stock split was set as September 12, 2025, preceding the dividend record date.

As a result of the stock split, the dividend payable has been adjusted to 0.5% of the revised face value of ₹1 per equity share, translating to ₹0.005 per share. Fischer Medical Ventures highlighted that this clarification aligns with their earlier intimations regarding the dividend recommendation and the stock split approval.